Ken Griffin Omnicell, Inc Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Omnicell, Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 16,500 shares of OMCL stock, worth $872,355. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,500

Previous 12,700 29.92%

Holding current value

$872,355

Previous $371,000 20.22%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$26.22 - $32.65 $617,638 - $769,103	-23,556 Reduced 5.7%	389,638 $10.5 Million
Q1 2024 May 15, 2024	BUY	$26.15 - $37.33 $9.62 Million - $13.7 Million	367,713 Added 808.5%	413,194 $12.1 Million
Q4 2023 Feb 14, 2024	BUY	$29.24 - $45.81 $1.33 Million - $2.08 Million	45,481 New	45,481 $1.71 Million
Q2 2023 Aug 14, 2023	BUY	$57.88 - $75.94 $5.2 Million - $6.83 Million	89,896 Added 149.5%	150,028 $11.1 Million
Q1 2023 May 15, 2023	BUY	$51.51 - $60.43 $1.31 Million - $1.53 Million	25,392 Added 73.09%	60,132 $3.53 Million
Q4 2022 Feb 14, 2023	SELL	$46.24 - $90.03 $14.4 Million - $28.1 Million	-312,179 Reduced 89.99%	34,740 $1.75 Million
Q3 2022 Nov 14, 2022	BUY	$84.23 - $117.38 $29.2 Million - $40.7 Million	346,919 New	346,919 $30.2 Million
Q1 2022 May 16, 2022	SELL	$120.68 - $180.51 $4.87 Million - $7.29 Million	-40,370 Reduced 61.7%	25,064 $3.25 Million
Q4 2021 Feb 14, 2022	SELL	$153.26 - $183.62 $2.59 Million - $3.1 Million	-16,872 Reduced 20.5%	65,434 $11.8 Million
Q3 2021 Nov 15, 2021	BUY	$141.84 - $160.88 $3.48 Million - $3.95 Million	24,526 Added 42.45%	82,306 $12.2 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $151.45 $4.96 Million - $5.79 Million	38,210 Added 195.25%	57,780 $8.75 Million
Q1 2021 May 17, 2021	SELL	$117.78 - $143.9 $3.21 Million - $3.92 Million	-27,219 Reduced 58.17%	19,570 $2.54 Million
Q4 2020 Feb 16, 2021	SELL	$73.85 - $120.02 $5.25 Million - $8.53 Million	-71,112 Reduced 60.32%	46,789 $5.62 Million
Q1 2020 May 15, 2020	BUY	$55.41 - $90.19 $1.8 Million - $2.93 Million	32,437 Added 37.95%	117,901 $7.73 Million
Q4 2019 Feb 14, 2020	BUY	$70.15 - $83.11 $218,166 - $258,472	3,110 Added 3.78%	85,464 $6.99 Million
Q3 2019 Nov 14, 2019	BUY	$68.36 - $88.34 $3.6 Million - $4.65 Million	52,594 Added 176.73%	82,354 $5.95 Million
Q2 2019 Aug 14, 2019	SELL	$71.38 - $92.21 $39,330 - $50,807	-551 Reduced 1.82%	29,760 $2.56 Million
Q1 2019 May 15, 2019	SELL	$58.88 - $86.19 $9.14 Million - $13.4 Million	-155,242 Reduced 83.66%	30,311 $0
Q4 2018 Feb 14, 2019	BUY	$56.97 - $77.23 $9.31 Million - $12.6 Million	163,342 Added 735.41%	185,553 $11.4 Million
Q2 2018 Aug 10, 2018	BUY	$42.2 - $53.05 $937,304 - $1.18 Million	22,211 New	22,211 $0

Others Institutions Holding OMCL

# of Institutions

262

Shares Held

45.9M

Call Options Held

153K

Put Options Held

33.2K

View Full List

About OMNICELL, Inc

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $2.34B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

More about OMCL

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account